Table 2 Outcome and adverse events
Characteristic | rhAPC group (n = 12) | Control group (n = 12) | p value |
|---|---|---|---|
28-day survivors, n | 10 | 9 | 1.00 |
Length of ICU stay, days | 15 ± 14 | 20 ± 15 | 0.41 |
Length of hospital stay, days, | 35 ± 20 | 46 ± 41 | 0.38 |
Patients discharged home (%) | 5 (41.7) | 5 (41.7) | 1.00 |
At least one adverse event, n | 9 | 7 | 0.41 |
Serious bleeding event, n | 1 | 0 | 0.33 |